New Content  edit

Challenging Cases in PH: You Decide the Outcome

An Interactive Satellite Symposium – Lunch provided!

Early registration is now closed. Please register on-site prior to the meeting.

Sunday October 7, 2018 11:45 AM- 1:00 PM
San Antonio Marriott Rivercenter - Salon CDE
San Antonio, TX

Earn CME credit when you attend ‘Challenging Cases in PH,’ an innovative satellite symposium held at the San Antonio Marriott Rivercenter in San Antonio, Texas. This interactive program allows the audience to decide the patient’s treatment path, while an expert faculty will discuss the outcomes of these challenging cases.

Using a blended learning concept or ‘flipped classroom’ approach, you will have an opportunity to test your knowledge before the program and compete with your peers during a quiz challenge.

So, how will YOU decide the patients’ fate?

Vallerie McLaughlin, MD

Kim A. Eagle Endowed Professor of Cardiovascular Medicine, Department of Internal Medicine/Cardiovascular Medicine, University of Michigan

Richard Channick, MD

Professor of Medicine Pulmonary and Critical Care Division David Geffen School of Medicine, UCLA

Ioana Preston, MD

Associate Professor of Medicine Director, Pulmonary Hypertension Center Director, Pulmonary Function Test Lab Tufts Medical Center

Victor Tapson, MD

Professor of Medicine Division of Pulmonary and Critical Care Cedars-Sinai Medical Center

Lunch will be provided!

Early Registration Closed

This program has exclusive pre and post symposium learning activities. Register now to access this content and fully experience the benefits of this interactive program.

Upon completion of registration, you will also be granted access to all MedEd On The Go content.

Physician's Continuing Education
1.0 AMA PRA Category 1 Credit™

See Full Accreditation and
Program Information

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians
Jointly provided by Postgraduate Institute for Medicine and TotalCME.
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.

Program Overview/Front Matter
Agenda:

11:45 am – 12:00 pm – Registration & Lunch
12:00 pm – 12:30 pm – Case 1: Aggressive Approaches to the WHO-1 Patient
12:30 pm – 1:00 pm – Case 2: Screening and Aggressive Care in the SSc/PH Patient

Program Chair:

Vallerie McLaughlin, MD
Kim A. Eagle Endowed Professor of Cardiovascular Medicine Department of Internal Medicine/Cardiovascular Medicine
University of Michigan

Faculty:

Richard Channick, MD
Professor of Medicine
Pulmonary and Critical Care Division
David Geffen School of Medicine, UCLA

Ioana Preston, MD

Associate Professor of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Tufts Medical Center

Victor Tapson, MD

Professor of Medicine
Division of Pulmonary and Critical Care
Cedars-Sinai Medical Center

Target Audience

This activity has been designed to meet the educational needs of physicians and other healthcare professionals involved in the care of patients with pulmonary hypertension.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe the latest data supporting the new and emerging PAH medications and delivery systems
  • Discuss the use of aggressive combination therapy approaches to PAH
  • Describe the components of the PH specialty center and how integration with primary care can benefit PAH patients
  • Utilize current and emerging practice guidelines for Group 1 PAH and non-Group 1 PH
  • Explain the timing of various therapies in the course of the patient's disease and whether earlier action on the prostacyclin pathway alone or in combination therapy benefits patients clinically
  • Illuminate the rationale for switching therapies to take advantage of alternative attack points in PAH pathophysiology
  • Present up-to-date clinical evidence regarding new treatment modalities and development programs.
Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Total CME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact Total CME prior to the live event at (267) 395-0001.

Fee Information

There is no fee for this educational activity.
Jointly provided by Postgraduate Institute for Medicine and TotalCME.
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.